# Mechanistic Hypotheses: TDP-43 → mPTP Opening Upstream Triggers
---
## Hypothesis 1: Cyclophilin D (CypD/PPID) Displacement by Mitochondrial TDP-43
**Title:** TDP-43 mitochondrial translocation displaces CypD inhibitors, sensitizing mPTP
**Mechanism:** Under pathological conditions, TDP-43 redistributes to mitochondria (PMID: 30850429) where it directly binds CypD or its inhibitory partners (e.g., Hsp90/PPIase network), displacing negative regulators and promoting pore opening.
**Target Gene/Protein:** PPID (cyclophilin D) or upstream modulator; TSPO receptor as anchoring scaffold
**Supporting Evidence:**
- CypD is the master sensitizer of mPTP opening (PMID: 25478730)
- TDP-43 accumulates in mitochondrial fractions from ALS spinal cord (PMID: 30850429)
- CypD inhibition is neuroprotective in ALS/ALS-FTD models (PMID: 29778753)
**Predicted Experiment:** co-IP/mitochondrial crosslinking mass spec to identify the TDP-43:CypD interactome in iPSC-derived motor neurons; test whether CypD knockout or inhibition blocks TDP-43-induced mtDNA release
**Confidence:** 0.72
---
## Hypothesis 2: TOM/TIM Complex Disruption Triggers Mitochondrial Integrated Stress Response (mtISR)
**Title:** TDP-43 aggregation blocks mitochondrial protein import, causing proteostatic collapse that triggers mPTP
**Mechanism:** Pathological TDP-43 species bind TOM/TIM translocase components, impairing import of nuclear-encoded mitochondrial proteins. This causes misfolded protein accumulation in the intermembrane space, triggering CHOP-mediated mPTP sensitization.
**Target Gene/Protein:** TOMM40/TOMM70 (outer membrane translocase); mitochondrial unfolded protein response (UPR^mt) effectors - CLPP protease
**Supporting Evidence:**
- TDP-43 was recently shown to physically interact with mitochondrial import machinery (PMID: 38245738, 2024)
- Impaired import causes mitochondrial proteostatic stress and activates mPTP (PMID: 36455972)
- Bcl-2 family proteins that regulate mPTP require correct mitochondrial targeting
**Predicted Experiment:** Mitochondrial matrix proteomics comparing import efficiency before/after TDP-43 aggregation; test whether overexpressing TOM70 or Hsp90 restores protein import and prevents mPTP opening
**Confidence:** 0.65
---
## Hypothesis 3: VDAC1 Hyper-Oligomerization via Direct TDP-43 Binding
**Title:** TDP-43 acts as a scaffold for VDAC1/2 oligomerization, bypassing CypD requirement for basal pore opening
**Mechanism:** TDP-43 contains intrinsically disordered regions that can bridge VDAC monomers, stabilizing large conductance channels. This directly increases basal mitochondrial permeability, promoting mtDNA release independent of CypD calcium sensing.
**Target Gene/Protein:** VDAC1 (VDAC1); VDAC2 as potential modifier
**Supporting Evidence:**
- VDAC1 oligomerization is sufficient to form mtDNA-permeable pores (PMID: 31439796)
- TDP-43 liquid-liquid phase separation properties could mediate membrane protein clustering
- VDAC1 is implicated in ALS genetic risk (PMID: 30636642)
**Predicted Experiment:** Blue-native PAGE of mitochondrial extracts to detect TDP-43:VDAC1 high-molecular-weight complexes; single-channel electrophysiology in planar lipid bilayers to test whether recombinant TDP-43 + VDAC1 creates large non-selective pores
**Confidence:** 0.58
---
## Hypothesis 4: Mitochondrial Calcium Uniporter (MCU) Overload from ER-Mitochondria Tether Dysfunction
**Title:** TDP-43 disrupts MAM integrity, uncoupling calcium signaling and causing mitochondrial Ca²⁺ overload that primes mPTP
**Mechanism:** TDP-43 pathology disrupts Mfn2/GRP75/VDAC1 ER-mitochondria contact sites (MAMs), causing dysregulated calcium transfer. Sustained mitochondrial Ca²⁺ loading—particularly combined with oxidative stress—exceeds the mitochondrial buffering capacity and triggers CypD-dependent mPTP opening.
**Target Gene/Protein:** MFN2, GRP75 (HSPA9), IP3R3 (ITPR1); MCU complex (MICU1/2 regulators)
**Supporting Evidence:**
- TDP-43 mislocalization disrupts ER-mitochondria contacts in FTD models (PMID: 32294224)
- MCU inhibition prevents mPTP in neurodegeneration models (PMID: 35839797)
- MAM dysfunction is an early event in ALS pathogenesis (PMID: 34634180)
**Predicted Experiment:** TIRF microscopy to quantify MAM integrity; genetically encoded mitochondrial Ca²⁺ sensors (mito-GCamp) to test whether TDP-43 pathology causes baseline mitochondrial Ca²⁺ elevation or exaggerated Ca²⁺ response to glutamate excitotoxicity
**Confidence:** 0.68
---
## Hypothesis 5: Drp1-Mediated Fission Priming Enables t-Bid–Driven MPTP Amplification
**Title:** TDP-43 activates Drp1-S616 phosphorylation, promoting mitochondrial fragmentation that creates isolated vulnerable organelles where t-Bid triggers mPTP
**Mechanism:** TDP-43 engages stress kinases (PKCδ, CDK5, or GSK3β) to phosphorylate Drp1 at S616, driving excessive fission. Fission generates small, isolated mitochondria with high surface-to-volume ratio that are sensitized to mPTP. tBid (truncated Bid) then binds to these organelles, further